ECDC - Considerations for the use of saliva as sample material for COVID-19 testing

ECDC - Considerations for the use of saliva as sample material for COVID-19 testing

European Centre for Disease Prevention and Control

Nasopharyngeal specimens remain the gold standard for COVID-19 testing for use with RT-PCR and rapid antigen diagnostic tests.

ECDC - Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

ECDC - Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

European Centre for Disease Prevention and ControlThe use of rapid antigen detection tests (RADTs) and/or self-test RADTs in occupational settings can complement, but not replace, occupational safety and health measures and existing...
ECDC - Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities

ECDC - Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities

European Centre for Disease Prevention and ControlThe main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks, by SARS-CoV-2 variant and vaccine product. This activity is not intended...
ECDC - Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

ECDC - Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

European Centre for Disease Prevention and Control

This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries.

ECDC - Objectives of vaccination strategies against COVID-19

ECDC - Objectives of vaccination strategies against COVID-19

European Centre for Disease Prevention and Control

This document provides an overview of the possible goals of vaccination against COVID-19 and reflects on potential implications.

DGS - COVID-19: Gravidez e Parto

DGS - COVID-19: Gravidez e Parto

Orientação da Direção-Geral da SaúdeA gravidez não aumenta o risco de infeção por SARS-CoV-2 mas aumenta o risco de progressão para doença grave (1,2). Deste modo, perante a reorganização dos recursos humanos e físicos afetos à prestação de...
DGS - COVID-19: Cuidados ao Recém-nascido na Maternidade

DGS - COVID-19: Cuidados ao Recém-nascido na Maternidade

Orientação da Direção-Geral da Saúde

A evolução científica impõe uma constante atualização dos modelos de abordagem clínica da COVID-19, continuamente adaptados à evolução epidemiológica e às medidas de Saúde Pública implementadas.

DGS - Abordagem do Doente com Suspeita ou Confirmação de COVID-19

DGS - Abordagem do Doente com Suspeita ou Confirmação de COVID-19

Norma da Direção-Geral da SaúdeA rápida evolução científica impõe uma atualização permanente da abordagem clínica das pessoas com suspeita e infeção confirmada por SARS-CoV-2, que se fundamente na evidência crescente, particularmente ao nível dos...
ECDC - Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions

ECDC - Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions

European Centre for Disease Prevention and ControlCOVID-19 vaccines licensed in the EU/EEA have been shown during clinical trials to be highly effective in providing protection against symptomatic and severe COVID-19. Evidence from real-life...
ECDC - Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

ECDC - Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

European Centre for Disease Prevention and ControlReinfection with SARS-CoV-2 has been reported both within the European Union/European Economic Area (EU/EEA) and globally. This report summarises the available evidence about reinfection and...
AMP - Obesity and COVID-19: Present and Future

AMP - Obesity and COVID-19: Present and Future

Acta Médica PortuguesaCom a chegada da COVID-19 à Europa e depois aos Estados Unidos, começou a avolumar-se a evidência que apontava a obesidade como uma das principais comorbilidades associadas a doença grave por COVID-19. Um dos primeiros...
NEJM - Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

NEJM - Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

The New England Journal of MedicineSeveral cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome...
AMP - Genomic Insights into the Human Susceptibility to SARS-CoV-2 Infection

AMP - Genomic Insights into the Human Susceptibility to SARS-CoV-2 Infection

Acta Médica PortuguesaOne year after the first reported case of COVID-19 in Portugal, on the 2nd of March 2020, we are acquiring knowledge at an unprecedented pace on this new infectious disease caused by the newly emerged SARS-CoV-2 virus. We...
NEJM - Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

NEJM - Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

The New England Journal of MedicineWe report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus...
NEJM - On the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines

NEJM - On the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines

The New England Journal of MedicineIn December 2020, on the basis of safety and efficacy data generated in two large, placebo-controlled studies, the Food and Drug Administration (FDA) issued emergency use authorizations for two mRNA vaccines for...
245678910Último
Categorias

Categorias

Arquivo de Notícias

Arquivo